Diagnostic accuracy and treatment approach to depression in primary care: predictive factors.


Journal

Family practice
ISSN: 1460-2229
Titre abrégé: Fam Pract
Pays: England
ID NLM: 8500875

Informations de publication

Date de publication:
25 01 2019
Historique:
pubmed: 14 11 2018
medline: 29 5 2019
entrez: 14 11 2018
Statut: ppublish

Résumé

The study assessed the predictive factors of diagnostic accuracy and treatment approach (antidepressants versus active monitoring) for depression in primary care. This is a cross-sectional study that uses information from a naturalistic prospective controlled trial performed in Barcelona (Spain) enrolling newly diagnosed patients with mild to moderate depression by GPs. Treatment approach was based on clinical judgement. Diagnosis was later assessed according to DSM-IV criteria using Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) interview by an external researcher. Patients (sociodemographic, psychiatric diagnosis, severity of depression and anxiety, health-related quality of life, disability, beliefs about medication and illness and comorbidities) and GP factors associated with diagnostic accuracy and treatment approach were assessed using multilevel logistic regression. Variables with missing data were imputed through multiple imputations. Two hundred sixty-three patients were recruited by 53 GPs. Mean age was 51 years (SD = 15). Thirty percent met DSM-IV criteria for major depression. Mean depression symptomatology was moderate-severe. Using multivariate analyses, patients' beliefs about medicines were the only variable associated with the antidepressant approach. Specialization in general medicine and being a resident tutor were associated with a more accurate diagnosis. Clinical depression diagnosis by GPs was not always associated with a formal diagnosis through a SCID-I. GPs' training background was central to an adequate depression diagnosis. Patients' beliefs in medication were the only factor associated with treatment approach. More resources should be allocated to improving the diagnosis of depression.

Identifiants

pubmed: 30423158
pii: 5174724
doi: 10.1093/fampra/cmy098
doi:

Substances chimiques

Antidepressive Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-11

Auteurs

Ignacio Aznar-Lou (I)

Teaching, Research and Innovation Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.
Fundació Idiap Jordi Gol i Gurina, Barcelona, Spain.

Maria Iglesias-González (M)

Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.
School of Medicine, University of Barcelona, Barcelona, Spain.

Maria Rubio-Valera (M)

Teaching, Research and Innovation Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.
Fundació Idiap Jordi Gol i Gurina, Barcelona, Spain.
Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.

M Teresa Peñarrubia-Maria (MT)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.
Fundació Idiap Jordi Gol i Gurina, Barcelona, Spain.
SAP Delta Llobregat, DAP Costa Ponent, Institut Català de la Salut, Catalonia, Spain.

Juan M Mendive (JM)

Fundació Idiap Jordi Gol i Gurina, Barcelona, Spain.
Primary Care Prevention and Health Promotion Research Network (redIAPP), Barcelona, Spain.
La Mina Primary Care Centre, Institut Català de la Salut, Sant Adrià de Besós, Spain.

Ana G Murrugarra-Centurión (AG)

Teaching, Research and Innovation Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Primary Care Prevention and Health Promotion Research Network (redIAPP), Barcelona, Spain.

Montserrat Gil-Girbau (M)

Teaching, Research and Innovation Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Fundació Idiap Jordi Gol i Gurina, Barcelona, Spain.
Primary Care Prevention and Health Promotion Research Network (redIAPP), Barcelona, Spain.

Laura González-Suñer (L)

Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.

Carmen Peuters (C)

Department of Movement and Sports Sciences, Ghent University, Belgium.

Antoni Serrano-Blanco (A)

Teaching, Research and Innovation Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.
Fundació Idiap Jordi Gol i Gurina, Barcelona, Spain.
Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.
School of Medicine, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH